REVENUE INTEREST FINANCING AGREEMENT between SPERO THERAPEUTICS INC., as the Company, and ENTITIES MANAGED BY HEALTHCARE ROYALTY MANAGEMENT, LLC, as the Investors Dated September 29, 2021Revenue Interest Financing Agreement • September 30th, 2021 • Spero Therapeutics, Inc. • Pharmaceutical preparations • New York
This REVENUE INTEREST FINANCING AGREEMENT (this “Agreement”) dated as of September 29, 2021 (the “Effective Date”) is between SPERO THERAPEUTICS INC., a Delaware corporation (the “Company”), and the entities managed by HEALTHCARE ROYALTY MANAGEMENT, LLC listed on the signature pages hereto (the “Investors”). Each of the Company and the Investors are referred to in this Agreement as a “Party” and collectively as the “Parties”.
SECURITY AGREEMENTSecurity Agreement • September 30th, 2021 • Spero Therapeutics, Inc. • Pharmaceutical preparations • New York
This SECURITY AGREEMENT, dated as of September 29, 2021 (as amended, restated, supplemented and otherwise modified from time to time, this “Security Agreement”), is by and among the parties identified as “Grantor” on the signature pages hereto and such other entities as may become “Grantor” hereunder after the date hereof (collectively, the “Grantor” and, individually, an “Individual Grantor”) and HCR COLLATERAL MANAGEMENT, LLC, as agent for the Investor under the Revenue Interest Financing Agreement (each, as defined below) (in such capacity, as secured party, the “Secured Party”).
